Zanosar

Zanosar (streptozocin) is an intravenous chemotherapy medication used primarily for pancreatic neuroendocrine tumors. This alkylating agent helps slow tumor growth by interfering with cancer cell DNA. Always consult a healthcare provider for personalized treatment guidance.

Zanosar is prescribed to treat pancreatic neuroendocrine tumors, including pancreatic islet cell carcinoma. It may also be used in research settings for other cancer types. Patients often ask, 'What is Zanosar used for?' to understand its role in managing specific tumors. The medication works by disrupting cancer cell reproduction, offering a targeted approach for certain malignancies.

Common effects of Zanosar include nausea, vomiting, or fatigue during treatment. Some patients may experience changes in kidney function or blood cell counts, which are monitored closely. Hair loss is less frequent compared to other chemotherapy drugs. Individual responses vary based on dosage and health status.

Zanosar requires careful handling and administration by healthcare professionals. Patients should disclose all medications, including supplements, to avoid potential interactions. Regular blood tests are essential to track kidney function and blood cell levels. Avoid pregnancy during treatment, as Zanosar may harm an unborn baby.

Zanosar may interact with medications that affect liver enzymes, such as certain antibiotics or antifungals. Combining it with other nephrotoxic drugs could increase kidney strain. Alcohol and vaccines may also pose risks during treatment. Always inform your doctor about all substances you use.